The ARPC5 Knockout HeLa Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population in which the ARPC5 gene has been disrupted to abolish expression of its protein product. This heterogeneous pool of edited cells provides a genetically defined loss-of-function model for investigating ARPC5-dependent processes without the confounding effects of clonal selection. The polyclonal format ensures a diverse representation of knockout alleles, making it suitable for studies that require population-level analysis of gene function.
The HeLa host cell line is a human epithelial cell line derived from a cervical adenocarcinoma, one of the most widely utilized models in biomedical research. These cells exhibit robust proliferation, adaptability to various culture conditions, and well-characterized cancer-associated properties, including deregulated actin dynamics and enhanced migratory potential. Their epithelial origin and transformed phenotype make them particularly relevant for studying mechanisms of tumor cell invasion and metastasis.
ARPC5 encodes a subunit of the Arp2/3 complex, which functions as the primary nucleator of branched actin filament networks. Upon activation by nucleation-promoting factors such as WAVE and N-WASP (encoded by WASL), which are downstream effectors of the small GTPases Rac1 and Cdc42, the Arp2/3 complex drives the formation of lamellipodial actin structures essential for cell motility. ARPC5 directly interacts with other complex components including ARPC1A, ARPC2, ARPC3, and ARPC4, as well as regulatory factors like CYFIP1, NCKAP1, and ABI1 within the WAVE complex, assembling a macromolecular machine that orchestrates actin cytoskeleton remodeling.
In the HeLa cell context, ARPC5 knockout disrupts the Arp2/3 complex integrity, impairing the cell??s ability to form branched actin networks required for lamellipodia extension and directional migration. Given that HeLa cells are a prototypic cancer cell line with heightened migratory and invasive capacities, this knockout model directly addresses the role of actin nucleation in cancer cell dissemination. It serves as a valuable tool for dissecting how ARPC5-mediated actin dynamics contribute to the metastatic phenotype of cervical adenocarcinoma cells.
This product is optimally suited for advanced research applications including live-cell imaging of actin dynamics using phalloidin staining, quantitative migration and invasion assays, and co-immunoprecipitation studies to assess ARPC5??s interaction with WAVE complex partners. It also supports western blotting and immunofluorescence to validate knockout efficiency and monitor downstream effects on actin organization. By enabling precise manipulation of the Arp2/3 complex in a well-established cancer cell line, these polyclonal knockout cells facilitate investigations into cytoskeletal organization, cell motility, and cancer metastasis. For additional technical details, please contact Ascent Research.
